Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2 studies found for:    CLEFT LARYNX, POSTERIOR
Show Display Options
Rank Status Study
1 Completed MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma
Condition: Cancer
Intervention: Drug: entinostat
2 Completed Thalidomide and Docetaxel in Treating Patients With Advanced Cancer
Condition: Cancer
Interventions: Drug: docetaxel;   Drug: thalidomide

Indicates status has not been verified in more than two years